Published in Curr Cardiol Rev on May 01, 2012
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med (2007) 10.87
Apixaban in patients with atrial fibrillation. N Engl J Med (2011) 9.97
Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med (2010) 9.92
Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med (2009) 9.17
Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet (1960) 7.96
Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med (2011) 7.30
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation (2011) 6.47
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med (2008) 6.32
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med (2008) 6.00
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med (2010) 5.59
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet (2007) 5.41
Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med (2011) 4.81
The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med (2009) 4.71
Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost (2010) 4.45
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost (2007) 3.66
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. Lancet (2010) 3.29
Apixaban or enoxaparin for thromboprophylaxis after knee replacement. N Engl J Med (2009) 2.90
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty (2008) 2.30
Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves. J Thorac Cardiovasc Surg (2011) 2.24
Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial. Eur Heart J (2011) 2.21
Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med (2007) 2.20
Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. Arch Intern Med (2007) 2.20
Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association. Circulation (2001) 2.01
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res (2010) 1.93
Beyond unfractionated heparin and warfarin: current and future advances. Circulation (2007) 1.52
Structure-based design of novel potent nonpeptide thrombin inhibitors. J Med Chem (2002) 1.51
The discovery of dicumarol and its sequels. Circulation (1959) 1.10
Mortality in patients treated for pulmonary embolism. JAMA (1976) 1.09
In vitro comparison of dabigatran, unfractionated heparin, and low-molecular-weight heparin in preventing thrombus formation on mechanical heart valves. Thromb Res (2010) 0.85
Effects on fibrin network porosity of anticoagulants with different modes of action and reversal by activated coagulation factor concentrate. Br J Haematol (2011) 0.84
Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro study. J Thromb Thrombolysis (2011) 0.80
Effect of pacing method on risk of sudden death after atrioventricular node ablation and pacemaker implantation in patients with atrial fibrillation. Heart Rhythm (2013) 1.99
Safety of wireless capsule endoscopy in patients with implantable cardiac defibrillators. Am J Gastroenterol (2005) 1.79
Safety of capsule endoscopy in patients with pacemakers. Gastrointest Endosc (2004) 1.04
Images in cardiovascular medicine. Real-time 3-dimensional transesophageal echocardiography: novel utility in atrial fibrillation ablation with a prosthetic mitral valve. Circulation (2008) 1.03
Left atrial reservoir function predicts atrial fibrillation recurrence after catheter ablation: a two-dimensional speckle strain study. J Interv Card Electrophysiol (2011) 0.99
Advances in management of premature ventricular contractions. J Interv Card Electrophysiol (2012) 0.94
Capsule Endoscopy in Patients with Implantable Electromedical Devices is Safe. Gastroenterol Res Pract (2013) 0.92
Atrial fibrillation ablation in cor triatriatum: value of intracardiac echocardiography. J Interv Card Electrophysiol (2009) 0.89
Radiotherapy-induced pacemaker and implantable cardioverter defibrillator malfunction. Expert Rev Med Devices (2009) 0.84
Noninvasive assessment of right atrial pressure using Doppler tissue imaging. J Am Soc Echocardiogr (2004) 0.82
Novel ECG criteria for right ventricular systolic dysfunction in patients with right bundle branch block. Int J Cardiol (2012) 0.80
Utilization of Electrocardiographic P-wave Duration for AV Interval Optimization in Dual-Chamber Pacemakers. Indian Pacing Electrophysiol J (2010) 0.77
Supraventricular and ventricular arrhythmias. Prim Care (2013) 0.77
Migraine headaches following catheter ablation for atrial fibrillation. J Interv Card Electrophysiol (2010) 0.77
Value of multislice computed tomography angiography of the thorax in preparation for catheter ablation for the treatment of atrial fibrillation: the impact of unexpected cardiac and extracardiac findings on patient care. Eur J Radiol (2008) 0.76
Ventricular arrhythmias: state of the art. Cardiol Clin (2013) 0.76
Exertional sudden cardiac death in a young athlete with anomalous origin of the left coronary artery from the opposite sinus. Europace (2008) 0.75
Radiofrequency ablation complicated by left atrial intramural hematoma. J Cardiovasc Electrophysiol (2011) 0.75
Linear segmental isolation of the left coronary cusp to eliminate ventricular arrhythmia originating in close proximity to left main coronary artery. J Interv Card Electrophysiol (2011) 0.75
Recent developments in the ablation of ventricular arrhythmias. Future Cardiol (2013) 0.75
Worsening left ventricular apical peak strain early after right ventricular pacing. Ultrasound Med Biol (2012) 0.75
Interventional management of atrial fibrillation. Expert Rev Cardiovasc Ther (2010) 0.75
Pacing polarity and left ventricular mechanical activation sequence in cardiac resynchronization therapy. J Interv Card Electrophysiol (2012) 0.75